|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 164.89 USD | -0.05% |
|
-1.21% | +33.89% |
| Dec. 11 | Jazz Pharmaceuticals Insider Sold Shares Worth $379,366, According to a Recent SEC Filing | MT |
| Dec. 10 | This Is Decision Day |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| $213 | +29.11% | 16 | |||||||
| $1,072.04 | +7.89% | 27 | |||||||
| $204.46 | -1.01% | 24 | |||||||
| $244.93 | +8.77% | 29 | |||||||
| CHF 320.95 | -0.33% | 18 | |||||||
| GBX 200.84 | +11.48% | 19 | |||||||
| CHF 135.31 | +3.06% | 19 | |||||||
| $107.39 | +10% | 26 | |||||||
| DKK 393.29 | +27.24% | 20 | |||||||
| $325.88 | +3.33% | 27 | |||||||
| $131.65 | +8.49% | 26 | |||||||
| $29.08 | +12.81% | 24 | |||||||
| €105.2 | +27.24% | 21 | |||||||
| $487.28 | +9.59% | 25 | |||||||
| $53.55 | +4.56% | 22 | |||||||
| GBX 18.64 | +3.33% | 18 | |||||||
| ¥8,571.43 | +5.17% | 14 | |||||||
| CN¥81.04 | +27.86% | 18 | |||||||
| $492.17 | +21.69% | 24 | |||||||
| Average | 694.11 | +11.59% | 22 | ||||||
| Weighted average by Cap. | 569.62 | +8.20% | 24 |
- Stock Market
- Equities
- JAZZ Stock
- Sector Jazz Pharmaceuticals plc
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
















